LTCPA Comment Documents

LTCPA Submits Comments to CMS on the Draft Medicare Drug Benefit Manual
  LTCPA recently submitted comments to CMS on the draft Medicare Prescription Drug Benefit Manual.
Read LTCPA's comments on Chapter 5 (PDF)
And Chapter 6 (PDF)
   
LTCPA Releases Comments on MMA Proposed Regulations
  The Long Term Care Pharmacy Alliance (LTCPA) appreciates this opportunity to respond to the Centers for Medicare and Medicaid Services (CMS) proposed rules to implement the Medicare Prescription Drug Benefit and establish the Medicare Advantage Program.
LTCPA Comments to CMS on MMA Proposed Regulations (PDF)
   
LTCPA Informs HHS About Impact of Proposed Rule Changes for Plan B Drug Reimbursment
  LTCPA recently sent comments to the Center for Medicare and Medicaid Services (CMS) regarding Proposed Rule entitled Payment Reform for Part B Drugs. 68 Fed. Reg. 50428 (Aug. 20, 2003). In our comments, we explore the impact in sufficient detail to allow CMS to adequately address the effects its reform proposals may have on the nationnâ?s oldest, sickest, and most frail population â? nursing home residents.
Read Our Letter (PDF)
Read Our Comments (PDF)
   
LTCPA Comments on HHS Proposed Rule to Implement President's Prescription Drug Discount-Card Initiative
  Submitted to the Department of Health and Human Services.
Read More (PDF)